http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 16 Sep 2024 11:01:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0500 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/TA+Associates+Announces+Strategic+Growth+Investment+in+Elos+Medtech/18722423.html si-local-file:///var/storage/newsbody/2021/0727/18722423.html http://www.streetinsider.com/Press+Releases/TA+Associates+Announces+Strategic+Growth+Investment+in+Elos+Medtech/18722423.html Tue, 27 Jul 2021 01:30:00 -0500 B ELOS http://www.streetinsider.com/Press+Releases/TA+Associates+Announces+Strategic+Growth+Investment+in+Elos+Medtech/18722423.html si-local-file:///var/storage/newsbody/2021/0727/18722423.html http://www.streetinsider.com/Press+Releases/TA+Associates+Announces+Strategic+Growth+Investment+in+Elos+Medtech/18722423.html Tue, 27 Jul 2021 01:30:00 -0500 B ELOS http://www.streetinsider.com/Business+Wire/TA+Associates+Announces+Strategic+Growth+Investment+in+Elos+Medtech/18722423.html si-local-file:///var/storage/newsbody/2021/0727/18722423.html http://www.streetinsider.com/Business+Wire/TA+Associates+Announces+Strategic+Growth+Investment+in+Elos+Medtech/18722423.html Tue, 27 Jul 2021 01:30:00 -0500 B ELOS http://www.streetinsider.com/Business+Wire/TA+Associates+Announces+Strategic+Growth+Investment+in+Elos+Medtech/18722423.html si-local-file:///var/storage/newsbody/2021/0727/18722423.html http://www.streetinsider.com/Business+Wire/TA+Associates+Announces+Strategic+Growth+Investment+in+Elos+Medtech/18722423.html Tue, 27 Jul 2021 01:30:00 -0500 B ELOS http://www.streetinsider.com/New+Coverage/Cantor+Fitzgerald+Starts+Syneron+Medical+%28ELOS%29+at+Overweight/13899281.html <p>Cantor Fitzgerald initiates coverage on Syneron Medical (NASDAQ: ELOS) with a Overweight rating and a price target of $25.00.</p><p>For an analyst ratings summary and ratings history on Syneron Medical <a href="http://www.streetinsider.com/rating_history.php?q=ELOS">click here</a>. For more ratings news on Syneron Medical <a href="http://www.streetinsider.com/stock_lookup_news.php?q=ELOS&amp;type=analyst">click here</a>.</p><p>Shares of Syneron Medical closed at $11.00 Friday.</p> http://www.streetinsider.com/New+Coverage/Cantor+Fitzgerald+Starts+Syneron+Medical+%28ELOS%29+at+Overweight/13899281.html Mon, 05 Mar 2018 00:12:44 -0500 ELOS http://www.streetinsider.com/Hot+New+Coverage/Cantor+Fitzgerald+Starts+Syneron+Medical+%28ELOS%29+at+Overweight/13899281.html <p>Cantor Fitzgerald initiates coverage on Syneron Medical (NASDAQ: ELOS) with a Overweight rating and a price target of $25.00.</p><p>For an analyst ratings summary and ratings history on Syneron Medical <a href="http://www.streetinsider.com/rating_history.php?q=ELOS">click here</a>. For more ratings news on Syneron Medical <a href="http://www.streetinsider.com/stock_lookup_news.php?q=ELOS&amp;type=analyst">click here</a>.</p><p>Shares of Syneron Medical closed at $11.00 Friday.</p> http://www.streetinsider.com/Hot+New+Coverage/Cantor+Fitzgerald+Starts+Syneron+Medical+%28ELOS%29+at+Overweight/13899281.html Mon, 05 Mar 2018 00:12:44 -0500 ELOS http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Syneron+Medical+Ltd.+++++++++++++++++++Filed+by%3A+European+High-Tech+Capital+S.A./13152441.html si-local-file:///var/storage/secattach/20170801/13152441.html http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Syneron+Medical+Ltd.+++++++++++++++++++Filed+by%3A+European+High-Tech+Capital+S.A./13152441.html Tue, 01 Aug 2017 09:48:00 -0500 ELOS http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Syneron+Medical+Ltd.+++++++++++++++++/13136140.html si-local-file:///var/storage/secattach/20170727/13136140.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Syneron+Medical+Ltd.+++++++++++++++++/13136140.html Thu, 27 Jul 2017 09:01:00 -0500 ELOS http://www.streetinsider.com/Press+Releases/Syneron+Candela+Completes+Previously+Announced+Transaction+with+Funds+Advised+by+Apax+Partners+and+Becomes+a+Private+Company/13104606.html si-local-file:///var/storage/newsbody/2017/0718/13104606.html http://www.streetinsider.com/Press+Releases/Syneron+Candela+Completes+Previously+Announced+Transaction+with+Funds+Advised+by+Apax+Partners+and+Becomes+a+Private+Company/13104606.html Tue, 18 Jul 2017 02:34:00 -0500 A.03295816 A.05436077 A.19553067 A.31825268 A.32072881 A.32686560 A.38918558 ELOS NVTA http://www.streetinsider.com/Press+Releases/Syneron+Candela+Completes+Previously+Announced+Transaction+with+Funds+Advised+by+Apax+Partners+and+Becomes+a+Private+Company/13104606.html si-local-file:///var/storage/newsbody/2017/0718/13104606.html http://www.streetinsider.com/Press+Releases/Syneron+Candela+Completes+Previously+Announced+Transaction+with+Funds+Advised+by+Apax+Partners+and+Becomes+a+Private+Company/13104606.html Tue, 18 Jul 2017 02:34:00 -0500 A.03295816 A.05436077 A.19553067 A.31825268 A.32072881 A.32686560 A.38918558 ELOS NVTA http://www.streetinsider.com/Press+Releases/Syneron+Candela+Completes+Previously+Announced+Transaction+with+Funds+Advised+by+Apax+Partners+and+Becomes+a+Private+Company/13104606.html si-local-file:///var/storage/newsbody/2017/0718/13104606.html http://www.streetinsider.com/Press+Releases/Syneron+Candela+Completes+Previously+Announced+Transaction+with+Funds+Advised+by+Apax+Partners+and+Becomes+a+Private+Company/13104606.html Tue, 18 Jul 2017 02:34:00 -0500 A.03295816 A.05436077 A.19553067 A.31825268 A.32072881 A.32686560 A.38918558 ELOS NVTA